Classification, Diagnosis, and Management of Cholangiocarcinoma

Overview

Journal Clin Gastroenterol Hepatol

Specialty Gastroenterology

Date 2012 Sep 18

PMID 22982100

Citations 136

Authors

Nataliya Razumilava

Gregory J Gores

Affiliations

Soon will be listed here.

Abstract

Cholangiocarcinomas (CCAs) are tumors that develop along the biliary tract. Depending on their site of origin, they have different features and require specific treatments. Classification of CCAs into intrahepatic, perihilar, and distal subgroups has helped standardize the registration, treatment, and study of this lethal malignancy. Physicians should remain aware that cirrhosis and viral hepatitis B and C are predisposing conditions for intrahepatic CCA. Treatment options under development include locoregional therapies and a chemotherapy regimen of gemcitabine and cisplatin. It is a challenge to diagnose perihilar CCA, but an advanced cytologic technique of fluorescence in situ hybridization for polysomy can aid in diagnosis. It is important to increase our understanding of the use of biliary stents and liver transplantation in the management of perihilar CCA, as well as to distinguish distal CCAs from pancreatic cancer, because of different outcomes from surgery. We review advances in the classification, diagnosis, and staging of CCA, along with treatment options.

Citing Articles

Research hotspots and trends in immunotherapy for cholangiocarcinoma: a bibliometric analysis (2014-2023).

Qu X, Wang Q, Zhu F, Liang H, Long Z, Wu Y Front Immunol. 2024; 15:1436315.

PMID: 39660136 PMC: 11628549. DOI: 10.3389/fimmu.2024.1436315.

Preoperative systemic inflammatory response index as a prognostic marker for distal cholangiocarcinoma after pancreatoduodenectomy.

Zhang W, Zhao Y, Zhang C, Huang J, Lyu S, Lang R World J Gastrointest Surg. 2024; 16(9):2910-2924.

PMID: 39351557 PMC: 11438816. DOI: 10.4240/wjgs.v16.i9.2910.

Tumor microenvironment and immunology of cholangiocarcinoma.

Cadamuro M, Fabris L, Zhang X, Strazzabosco M Hepatoma Res. 2024; 8.

PMID: 39301518 PMC: 11412615. DOI: 10.20517/2394-5079.2021.140.

Long-Term Survivor of Intrahepatic Cholangiocarcinoma for over 18 Years: Case Study with Longitudinal Histo-molecular and Tumor Immune Microenvironment Characterization and Systematic Review of the Literature.

Mattiolo P, De Bellis M, Mafficini A, Fassan M, Bevere M, Ciulla C J Gastrointest Cancer. 2024; 55(4):1634-1646.

PMID: 39283582 PMC: 11464565. DOI: 10.1007/s12029-024-01113-8.

Identification of autoantibodies as potential non-invasive biomarkers for intrahepatic cholangiocarcinoma.

Kajornsrichon W, Chaisaingmongkol J, Pomyen Y, Tit-Oon P, Wang X, Ruchirawat M Sci Rep. 2024; 14(1):20012.

PMID: 39198554 PMC: 11358490. DOI: 10.1038/s41598-024-70595-0.

References

DeOliveira M, Cunningham S, Cameron J, Kamangar F, Winter J, Lillemoe K . Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution. Ann Surg. 2007; 245(5):755-62. PMC: 1877058. DOI: 10.1097/01.sla.0000251366.62632.d3. View

Razumilava N, Gores G, Lindor K . Cancer surveillance in patients with primary sclerosing cholangitis. Hepatology. 2011; 54(5):1842-52. PMC: 3205332. DOI: 10.1002/hep.24570. View

Van Der Gaag N, Rauws E, van Eijck C, Bruno M, van der Harst E, Kubben F . Preoperative biliary drainage for cancer of the head of the pancreas. N Engl J Med. 2010; 362(2):129-37. DOI: 10.1056/NEJMoa0903230. View

Levy M, Heimbach J, Gores G . Endoscopic ultrasound staging of cholangiocarcinoma. Curr Opin Gastroenterol. 2012; 28(3):244-52. DOI: 10.1097/MOG.0b013e32835005bc. View

Fan B, Malato Y, Calvisi D, Naqvi S, Razumilava N, Ribback S . Cholangiocarcinomas can originate from hepatocytes in mice. J Clin Invest. 2012; 122(8):2911-5. PMC: 3408746. DOI: 10.1172/JCI63212. View

Helzberg J, Petersen J, Boyer J . Improved survival with primary sclerosing cholangitis. A review of clinicopathologic features and comparison of symptomatic and asymptomatic patients. Gastroenterology. 1987; 92(6):1869-75. DOI: 10.1016/0016-5085(87)90618-4. View

Heimbach J, Sanchez W, Rosen C, Gores G . Trans-peritoneal fine needle aspiration biopsy of hilar cholangiocarcinoma is associated with disease dissemination. HPB (Oxford). 2011; 13(5):356-60. PMC: 3093648. DOI: 10.1111/j.1477-2574.2011.00298.x. View

Isayama H, Komatsu Y, Tsujino T, Sasahira N, Hirano K, Toda N . A prospective randomised study of "covered" versus "uncovered" diamond stents for the management of distal malignant biliary obstruction. Gut. 2004; 53(5):729-34. PMC: 1774024. DOI: 10.1136/gut.2003.018945. View

Welzel T, Graubard B, El-Serag H, Shaib Y, Hsing A, Davila J . Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population-based case-control study. Clin Gastroenterol Hepatol. 2007; 5(10):1221-8. PMC: 2083573. DOI: 10.1016/j.cgh.2007.05.020. View

10.

Gonda T, Glick M, Sethi A, Poneros J, Palmas W, Iqbal S . Polysomy and p16 deletion by fluorescence in situ hybridization in the diagnosis of indeterminate biliary strictures. Gastrointest Endosc. 2011; 75(1):74-9. DOI: 10.1016/j.gie.2011.08.022. View

11.

Patel A, Harnois D, Klee G, Larusso N, Gores G . The utility of CA 19-9 in the diagnoses of cholangiocarcinoma in patients without primary sclerosing cholangitis. Am J Gastroenterol. 2000; 95(1):204-7. DOI: 10.1111/j.1572-0241.2000.01685.x. View

12.

Goodman Z, Ishak K, Langloss J, Sesterhenn I, Rabin L . Combined hepatocellular-cholangiocarcinoma. A histologic and immunohistochemical study. Cancer. 1985; 55(1):124-35. DOI: 10.1002/1097-0142(19850101)55:1<124::aid-cncr2820550120>3.0.co;2-z. View

13.

DeOliveira M, Schulick R, Nimura Y, Rosen C, Gores G, Neuhaus P . New staging system and a registry for perihilar cholangiocarcinoma. Hepatology. 2011; 53(4):1363-71. DOI: 10.1002/hep.24227. View

14.

Lan B, Kwee S, Wong L . Positron emission tomography in hepatobiliary and pancreatic malignancies: a review. Am J Surg. 2012; 204(2):232-41. PMC: 3454495. DOI: 10.1016/j.amjsurg.2011.07.025. View

15.

Bismuth H, Corlette M . Intrahepatic cholangioenteric anastomosis in carcinoma of the hilus of the liver. Surg Gynecol Obstet. 1975; 140(2):170-8. View

16.

Kahaleh M, Tokar J, Conaway M, Brock A, Le T, Adams R . Efficacy and complications of covered Wallstents in malignant distal biliary obstruction. Gastrointest Endosc. 2005; 61(4):528-33. DOI: 10.1016/s0016-5107(04)02593-3. View

17.

Murad S, Kim W, Harnois D, Douglas D, Burton J, Kulik L . Efficacy of neoadjuvant chemoradiation, followed by liver transplantation, for perihilar cholangiocarcinoma at 12 US centers. Gastroenterology. 2012; 143(1):88-98.e3. PMC: 3846443. DOI: 10.1053/j.gastro.2012.04.008. View

18.

Welzel T, Mellemkjaer L, Gloria G, Sakoda L, Hsing A, El Ghormli L . Risk factors for intrahepatic cholangiocarcinoma in a low-risk population: a nationwide case-control study. Int J Cancer. 2006; 120(3):638-41. DOI: 10.1002/ijc.22283. View

19.

Sapisochin G, Fidelman N, Roberts J, Yao F . Mixed hepatocellular cholangiocarcinoma and intrahepatic cholangiocarcinoma in patients undergoing transplantation for hepatocellular carcinoma. Liver Transpl. 2011; 17(8):934-42. DOI: 10.1002/lt.22307. View

20.

Shaib Y, El-Serag H, Davila J, Morgan R, McGlynn K . Risk factors of intrahepatic cholangiocarcinoma in the United States: a case-control study. Gastroenterology. 2005; 128(3):620-6. DOI: 10.1053/j.gastro.2004.12.048. View